Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Pharma Forum Oy
OY
Active
Y-tunnus 1944833-1
Eerikinkatu 1A-121, 20100
Turku
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2005 · 21 years old
— employees
Share
Finland
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Pharma Forum Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
0M
-1M
-1M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2024: 0M
0M
2024
2025: 0M
0M
2025
EBITDA
EUR millions
883M
662M
441M
221M
0M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2024: 709M
709M
2024
2025: 0M (-100% vs 2024)
0M
-100%
2025
Income statement
EUR thousands
Item
2025
2024
2022
2021
2020
Revenue
26
20
22
21
25
Staff expenses
−0
−0
−5
−5
−5
EBITDA
12
709 099
3
2
7
Depreciation & amort.
−7
−709 098
−7
−8
−9
EBIT
5
1
−4
−6
−1
Net financials
−19
—
−6
−6
−6
Profit before tax
−14
—
−10
−12
−7
Tax
−0
−0
−0
−0
−0
Net profit
−14
−18
−10
−12
−7
Balance sheet
EUR thousands
Item
2025
2024
2022
2021
2020
Total assets
233
1 117 318
253
269
277
Equity
−212
2
−178
−168
−156
Long-term debt
9
241 571
371
373
376
Short-term debt
436
6 802 643
60
63
57
Total debt
445
7 044 214
430
437
433
Financial ratios
5-year trend
EBITDA margin
47,1 %
This company
15,8 %
Market median
This company
Market median
198% above market
2020
2025
Equity ratio
−90,8 %
This company
38,2 %
Market median
This company
Market median
338% below market
2020
2025
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2020
2025
Net profit margin
−52,2 %
This company
8,1 %
Market median
This company
Market median
744% below market
2020
2025
Asset turnover
0,11×
This company
1,12×
Market median
This company
Market median
90% below market
2020
2025
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2020
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2024-04-01 – 2025-03-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-04-01 – 2022-03-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-04-01 – 2021-03-31
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2019-04-01 – 2020-03-31
View
PDF
More on Pharma Forum Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
